In a report issued on May 5, Andrew Berens from SVB Securities assigned a Buy rating to AVEO Pharma (AVEO – Research Report), with a price target of $15.00. The company's shares closed last Friday at $4.31. According to TipRanks.com, Berens is ranked 0 out of 5 stars with an average return of -13.5% and a 36.1% success rate. Berens covers the Healthcare sector, focusing on stocks such as Forma Therapeutics Holdings, Turning Point Therapeutics, and Global Blood Therapeutics. Currently, the analyst consensus on AVEO Pharma is a Strong Buy with an average price target of $15.75, representing a 246.2% upside. In a report issued on May 5, Robert W.
https://www.tipranks.com/news/blurbs/aveo-pharma-aveo-receives-a-buy-from-svb-securities?utm_source=advfn.com&utm_medium=referral
AVEO Pharmaceuticals (NASDAQ:AVEO)
Historical Stock Chart
From Oct 2022 to Nov 2022 Click Here for more AVEO Pharmaceuticals Charts.
AVEO Pharmaceuticals (NASDAQ:AVEO)
Historical Stock Chart
From Nov 2021 to Nov 2022 Click Here for more AVEO Pharmaceuticals Charts.